Investing in Healthcare and Energy for the Next Five Years
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy ENB?
Source: Fool
- AbbVie's Market Potential: AbbVie (ABBV), the third-largest healthcare company globally, is expected to see significant market expansion in immunology, neuroscience, and oncology, particularly as aging populations increase demand for its 12 blockbuster drugs, enhancing future revenue growth potential.
- Stable Dividend Returns: AbbVie offers a dividend yield of approximately 3% and is a member of the Dividend Kings, having increased its dividend for 50 consecutive years, showcasing strong cash flow and profitability that attract income investors.
- Enbridge's Growth Opportunities: Enbridge (ENB) has identified around $50 billion in growth opportunities through 2030, particularly driven by strong natural gas demand from industrial expansion and data centers in North America, solidifying its leadership in the energy market.
- Long-term Dividend Growth: Enbridge boasts a dividend yield of 5.4% and has increased its dividend for 31 consecutive years, with projections of around 5% annual growth in earnings and distributable cash flow, ensuring its appeal to income investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ENB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ENB
Wall Street analysts forecast ENB stock price to rise
10 Analyst Rating
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 51.440
Low
45.79
Averages
53.54
High
69.00
Current: 51.440
Low
45.79
Averages
53.54
High
69.00
About ENB
Enbridge Inc. is an energy transportation and distribution company. The Company's segments include Liquids Pipelines, Gas Transmission, Gas Distribution and Storage, and Renewable Power Generation. Liquids Pipelines consists of pipelines and terminals in Canada and United States that transport and export various grades of crude oil and other liquid hydrocarbons, including the Mainline System, Regional Oil Sands System, Gulf Coast and Mid-Continent, and Other. Gas Transmission consists of its investments in natural gas pipelines and gathering and processing facilities in Canada and United States, including United States Gas Transmission, Canadian Gas Transmission, United States Midstream, and Other. Gas Distribution and Storage consists of its rate-regulated natural gas utility operations in Canada and United States. Renewable Power Generation consists primarily of investments in wind and solar assets, as well as equity interests in geothermal power and power transmission assets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Enbridge Inc. Share Price Soars 7.07% Following Strong Q4 Results
- Earnings Beat: Enbridge Inc. reported an adjusted EPS of $0.65 for Q4 2025, exceeding estimates by $0.08, with quarterly revenue growing over 10% YoY to $12.61 billion, surpassing forecasts by $3.33 billion, indicating robust financial performance.
- Net Profit Surge: The company's net profit for Q4 quadrupled to C$1.95 billion compared to C$493 million in the same quarter last year, reflecting strong profitability in oil and gas transportation and distribution, further solidifying its market position.
- Strong Project Backlog: As of the end of FY 2025, Enbridge had a project backlog worth approximately C$39 billion, with around C$8 billion expected to come online this year, providing substantial support for future revenue growth.
- Consistent Dividend Growth: Enbridge has increased its dividend for 31 consecutive years, highlighting its status as a dividend aristocrat, with the CEO noting that the company exceeded its 2025 guidance for both EBITDA and DCF per share, demonstrating long-term financial stability and investment appeal.
See More
Investing in Healthcare and Energy for the Next Five Years
- AbbVie's Market Potential: AbbVie (ABBV), the third-largest healthcare company globally, is expected to see significant market expansion in immunology, neuroscience, and oncology, particularly as aging populations increase demand for its 12 blockbuster drugs, enhancing future revenue growth potential.
- Stable Dividend Returns: AbbVie offers a dividend yield of approximately 3% and is a member of the Dividend Kings, having increased its dividend for 50 consecutive years, showcasing strong cash flow and profitability that attract income investors.
- Enbridge's Growth Opportunities: Enbridge (ENB) has identified around $50 billion in growth opportunities through 2030, particularly driven by strong natural gas demand from industrial expansion and data centers in North America, solidifying its leadership in the energy market.
- Long-term Dividend Growth: Enbridge boasts a dividend yield of 5.4% and has increased its dividend for 31 consecutive years, with projections of around 5% annual growth in earnings and distributable cash flow, ensuring its appeal to income investors.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives that could influence investor decisions.
- Market Dynamics Overview: While specific stock names are not mentioned, analyst rating changes typically have a direct impact on the stock prices of the affected companies, prompting investors to closely monitor these shifts to optimize their portfolios.
- Impact of Rating Changes: Adjustments in analyst ratings can lead to fluctuations in market sentiment, particularly when investor expectations shift regarding certain stocks, thereby affecting trading activity in the short term.
- Investor Focus: Investors are encouraged to visit the analyst ratings page for a comprehensive view of rating changes, aiding them in making more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these firms' prospects.
- Market Reaction Insight: While specific rating changes are not detailed, analysts' opinions typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: As investors consider buying CSW stock, analysts' views will serve as a crucial reference, particularly in the current market environment where rating changes can significantly impact investor confidence.
- Impact of Rating Changes: Adjustments in analysts' ratings not only affect short-term stock prices but may also have profound implications for the companies' long-term strategic development, necessitating investors to closely monitor these changes for informed decision-making.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives that could influence investor decisions.
- Market Reaction Expectations: Changes in analyst ratings may lead to short-term volatility in the affected stocks, prompting investors to closely monitor these shifts to timely adjust their portfolios for optimized returns.
- Impact of Rating Changes: Upgrades typically boost investor confidence and may drive stock prices higher, while downgrades can trigger sell-offs, impacting company valuations, necessitating careful evaluation by investors.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including specific upgrades and downgrades, it is recommended to visit the analyst ratings page for broader market insights.
See More
Enbridge Downgraded to Hold by Jefferies Amid Growth Concerns
- Rating Downgrade Impact: Jefferies downgraded Enbridge from Buy to Hold with a C$76 price target, resulting in a 3.3% drop in stock price on Tuesday, reflecting a market reassessment of its growth prospects.
- Historical Price Peak: Although shares reached all-time highs last Friday, driven more by positive commentary on Venezuela than by a strong Q4 earnings report, Jefferies analyst noted that this rally was largely sentiment-driven.
- Long-Term Growth Guidance Maintained: Enbridge has maintained its FY 2026 and long-term growth guidance, expecting to issue final investment decisions for additional gas projects later this year, indicating confidence in future development.
- Valuation Comparison: Enbridge currently trades at 12.8x and 12.2x on 2027 and 2028 EBITDA, respectively, and despite a 12% year-to-date increase, it trades at a ~0.5x discount to TC Energy, reflecting market recognition of the latter's greater growth visibility.
See More
Enbridge Inc. Share Price Soars 7.07% Following Strong Q4 Results
- Earnings Beat: Enbridge Inc. reported an adjusted EPS of $0.65 for Q4 2025, exceeding estimates by $0.08, with quarterly revenue growing over 10% YoY to $12.61 billion, surpassing forecasts by $3.33 billion, indicating robust financial performance.
- Net Profit Surge: The company's net profit for Q4 quadrupled to C$1.95 billion compared to C$493 million in the same quarter last year, reflecting strong profitability in oil and gas transportation and distribution, further solidifying its market position.
- Strong Project Backlog: As of the end of FY 2025, Enbridge had a project backlog worth approximately C$39 billion, with around C$8 billion expected to come online this year, providing substantial support for future revenue growth.
- Consistent Dividend Growth: Enbridge has increased its dividend for 31 consecutive years, highlighting its status as a dividend aristocrat, with the CEO noting that the company exceeded its 2025 guidance for both EBITDA and DCF per share, demonstrating long-term financial stability and investment appeal.
See More
Investing in Healthcare and Energy for the Next Five Years
- AbbVie's Market Potential: AbbVie (ABBV), the third-largest healthcare company globally, is expected to see significant market expansion in immunology, neuroscience, and oncology, particularly as aging populations increase demand for its 12 blockbuster drugs, enhancing future revenue growth potential.
- Stable Dividend Returns: AbbVie offers a dividend yield of approximately 3% and is a member of the Dividend Kings, having increased its dividend for 50 consecutive years, showcasing strong cash flow and profitability that attract income investors.
- Enbridge's Growth Opportunities: Enbridge (ENB) has identified around $50 billion in growth opportunities through 2030, particularly driven by strong natural gas demand from industrial expansion and data centers in North America, solidifying its leadership in the energy market.
- Long-term Dividend Growth: Enbridge boasts a dividend yield of 5.4% and has increased its dividend for 31 consecutive years, with projections of around 5% annual growth in earnings and distributable cash flow, ensuring its appeal to income investors.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives that could influence investor decisions.
- Market Dynamics Overview: While specific stock names are not mentioned, analyst rating changes typically have a direct impact on the stock prices of the affected companies, prompting investors to closely monitor these shifts to optimize their portfolios.
- Impact of Rating Changes: Adjustments in analyst ratings can lead to fluctuations in market sentiment, particularly when investor expectations shift regarding certain stocks, thereby affecting trading activity in the short term.
- Investor Focus: Investors are encouraged to visit the analyst ratings page for a comprehensive view of rating changes, aiding them in making more informed investment decisions.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these firms' prospects.
- Market Reaction Insight: While specific rating changes are not detailed, analysts' opinions typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: As investors consider buying CSW stock, analysts' views will serve as a crucial reference, particularly in the current market environment where rating changes can significantly impact investor confidence.
- Impact of Rating Changes: Adjustments in analysts' ratings not only affect short-term stock prices but may also have profound implications for the companies' long-term strategic development, necessitating investors to closely monitor these changes for informed decision-making.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives that could influence investor decisions.
- Market Reaction Expectations: Changes in analyst ratings may lead to short-term volatility in the affected stocks, prompting investors to closely monitor these shifts to timely adjust their portfolios for optimized returns.
- Impact of Rating Changes: Upgrades typically boost investor confidence and may drive stock prices higher, while downgrades can trigger sell-offs, impacting company valuations, necessitating careful evaluation by investors.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including specific upgrades and downgrades, it is recommended to visit the analyst ratings page for broader market insights.
See More
Enbridge Downgraded to Hold by Jefferies Amid Growth Concerns
- Rating Downgrade Impact: Jefferies downgraded Enbridge from Buy to Hold with a C$76 price target, resulting in a 3.3% drop in stock price on Tuesday, reflecting a market reassessment of its growth prospects.
- Historical Price Peak: Although shares reached all-time highs last Friday, driven more by positive commentary on Venezuela than by a strong Q4 earnings report, Jefferies analyst noted that this rally was largely sentiment-driven.
- Long-Term Growth Guidance Maintained: Enbridge has maintained its FY 2026 and long-term growth guidance, expecting to issue final investment decisions for additional gas projects later this year, indicating confidence in future development.
- Valuation Comparison: Enbridge currently trades at 12.8x and 12.2x on 2027 and 2028 EBITDA, respectively, and despite a 12% year-to-date increase, it trades at a ~0.5x discount to TC Energy, reflecting market recognition of the latter's greater growth visibility.
See More
